Literature DB >> 12023354

The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines.

Anette Gjörloff Wingren1, Radinka Hadzic, Arne Forsgren, Kristian Riesbeck.   

Abstract

Moraxella IgD binding protein (MID) is a novel bacterial outer membrane protein with IgD-binding properties. MID was purified from the respiratory pathogen Moraxella catarrhalis and is here shown to have B cell stimulatory properties. Purified MID in the range of 0.01-0.1 microg/ml was optimal to induce a proliferative response in human PBL. MID coupled to Sepharose and formalin-fixed M. catarrhalis preparations induced similar proliferative responses in PBL cultures. MID or MID-Sepharose stimulated purified human peripheral B cells as measured by proliferation. In contrast, MID or MID-Sepharose did not activate T cells. Preincubation of purified B cells with anti-IgD Abs inhibited MID-Sepharose-induced B cell proliferation. The addition of IL-4 specifically induced IL-6 production in MID-Sepharose-activated B cells. IgM secretion was detected in B cell cultures stimulated with MID or MID-Sepharose and IL-2 for 10 days. Secretion of IgG and IgA was efficiently induced in cultures from purified B cells stimulated with the combination of MID or MID-Sepharose and IL-4, IL-10, and soluble CD40 ligand, suggesting that Th2-derived cytokines were required for optimal plasma cell generation. Taken together, MID has properties that make it an important tool to study IgD-targeted activation of B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12023354     DOI: 10.4049/jimmunol.168.11.5582

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin.

Authors:  Arne Forsgren; Marta Brant; Mirela Karamehmedovic; Kristian Riesbeck
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  A fusion protein derived from Moraxella catarrhalis and Neisseria meningitidis aimed for immune modulation of human B cells.

Authors:  Oindrilla Mukherjee; Birendra Singh; Burcu Bayrak; Ann-Beth Jonsson; Matthias Mörgelin; Kristian Riesbeck
Journal:  Hum Vaccin Immunother       Date:  2015-06-04       Impact factor: 3.452

3.  Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis.

Authors:  Jin-Young Min; Jayakar V Nayak; Kathryn E Hulse; Whitney W Stevens; Paul A Raju; Julia H Huang; Lydia A Suh; Griet A Van Roey; James E Norton; Roderick G Carter; Caroline P E Price; Ava R Weibman; Ali R Rashan; Eliver E Ghosn; Zara M Patel; Tetsuya Homma; David B Conley; Kevin C Welch; Stephanie Shintani-Smith; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Atsushi Kato; Peter H Hwang; Robert C Kern; Leonore A Herzenberg; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2017-06-16       Impact factor: 10.793

4.  The invasin D protein from Yersinia pseudotuberculosis selectively binds the Fab region of host antibodies and affects colonization of the intestine.

Authors:  Pooja Sadana; Rebecca Geyer; Joern Pezoldt; Saskia Helmsing; Jochen Huehn; Michael Hust; Petra Dersch; Andrea Scrima
Journal:  J Biol Chem       Date:  2018-03-13       Impact factor: 5.157

5.  Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro.

Authors:  Brian Mocca; Wei Wang
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

6.  The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.

Authors:  Andrea Möllenkvist; Therése Nordström; Christer Halldén; Jens Jørgen Christensen; Arne Forsgren; Kristian Riesbeck
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

7.  The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.

Authors:  Melissa M Holm; Serena L Vanlerberg; Darren D Sledjeski; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 8.  A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

9.  Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities.

Authors:  Jennifer M Timpe; Melissa M Holm; Serena L Vanlerberg; Venkatesha Basrur; Eric R Lafontaine
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  B cell activation by outer membrane vesicles--a novel virulence mechanism.

Authors:  Maria Laura A Perez Vidakovics; Johan Jendholm; Matthias Mörgelin; Anne Månsson; Christer Larsson; Lars-Olaf Cardell; Kristian Riesbeck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.